| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2025―Jan―23 |
Editorial: COVID-19 and the central nervous system: Emerging insights from experimental neurology |
Takayoshi Shimohata |
| 2 |
[GO] |
2024―Oct―18 |
SARS-CoV-2 spike S1 protein induces microglial NLRP3-dependent neuroinflammation and cognitive impairment in mice |
Qiuhong Jiang, Ge Li, Huacheng Wang, Weineng Chen, Fengyin Liang, Haifan Kong, Tara S.R. Chen, Lishan Lin, Hua Hong, Zhong Pei |
| 3 |
[GO] |
2024―Oct―03 |
Neuro-inflammatory pathways in COVID-19-induced central nervous system injury: Implications for prevention and treatment strategies |
Muhammad Liaquat Raza, Mustafa Hussain Imam, Warisha Zehra, Subia Jamil |
| 4 |
[GO] |
2024―Aug―09 |
Insights into COVID-19 pathophysiology from a longitudinal multisystem report during acute infection |
Nabila Brihmat, Mehmed B. Bayram, Akhil Bheemreddy, Soha Saleh, Guang H. Yue, Gail F. Forrest |
| 5 |
[GO] |
2024―Jul―31 |
Neurotoxic effects of coronavirus: Potential implications in Alzheimer's onset and progression |
Francesca Beretti, Martina Gatti, Francesco Ricchi, Francesco Lipani, Pietro Cortelli, Claudio Cermelli, Tullia Maraldi |
| 6 |
[GO] |
2024―Jul―20 |
Neuro-molecular perspectives on long COVID-19 impacted cerebrovascular diseases - a role for dipeptidyl peptidase IV |
Umadevi V. Wesley, Robert J. Dempsey |
| 7 |
[GO] |
2023―Mar―11 |
The original strain of SARS-CoV-2, the Delta variant, and the Omicron variant infect microglia efficiently, in contrast to their inability to infect neurons: Analysis using 2D and 3D cultures |
Yoshitaka Kase, Iki Sonn, Maraku Goto, Rei Murakami, Tsukika Sato, Hideyuki Okano |
| 8 |
[GO] |
2021―Aug―13 |
ACE2 expression in rat brain: Implications for COVID-19 associated neurological manifestations |
Vito S. Hernández, Mario A. Zetter, Enrique C. Guerra, Ileana Hernández-Araiza, Nikita Karuzin, Oscar R. Hernández-Pérez, Lee E. Eiden, Limei Zhang |
|
